This inventor holds 1 USPTO granted patent, plus 2 CIPO patents. Top assignee: Akzo Nobel N.v.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Joannes Theodorus Linders: Innovator in Psychiatric Treatment
Introduction
Joannes Theodorus Linders is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of psychiatric disorders. His innovative work has led to the development of novel compounds that hold promise for improving mental health therapies.
Latest Patents
Linders holds a patent for benzylamine derivatives that are useful in treating psychiatric conditions. The patent details the preparation of these novel compounds, their pharmaceutical formulations, and their application in medical therapy, especially for treating depression. This invention represents a significant advancement in the search for effective treatments for mental health issues.
Career Highlights
Throughout his career, Joannes Theodorus Linders has worked with prominent companies in the pharmaceutical industry. He has been associated with Akzo Nobel N.V. and Organon Biosciences Nederland B.V., where he contributed to various research and development projects. His work has been instrumental in advancing therapeutic options for patients suffering from psychiatric disorders.
Collaborations
Linders has collaborated with several professionals in his field, including Simon James Grove and Simon N. Thorn. These collaborations have fostered a productive environment for innovation and have led to the successful development of new therapeutic agents.
Conclusion
Joannes Theodorus Linders is a distinguished inventor whose work in developing benzylamine derivatives has the potential to transform psychiatric treatment. His contributions to the pharmaceutical industry highlight the importance of innovation in addressing mental health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
